AKR1C3-IN-9 is a selective inhibitor of Aldo-keto Reductase 1C3 (AKR1C3) with an IC 50 value of 8.92 nM. AKR1C3-IN-9 significantly reverses the Doxorubicin ( HY-15142A ) (DOX) resistance in a resistant breast cancer cell line. IC50& Target:IC50: 8.92 nM (AKR1C3) In Vitro:AKR1C3-IN-9 (compound 24) (10-100 μM; 72 h and 96 h) results weak antiproliferative effect up to 100 μM in all three breast cancer cell lines (MDA-MB-231, MCF-7). AKR1C3-IN-9 (10 μM, 25 μM, and 50 μM; 72 h) synergistically inhibits the proliferation Biological Activity:AKR1C3-IN-9 is a selective inhibitor of Aldo-keto Reductase 1C3 (AKR1C3) with an IC 50 value of 8.92 nM. AKR1C3-IN-9 significantly reverses the Doxorubicin ( HY-15142A ) (DOX) resistance in a resistant breast cancer cell line.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
AKR1C3-IN-9
CAS number：unknown molecular formula：C20H20N2O4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | unknown | molecular formula | C20H20N2O4 |
| molecular weight | 352.38 g/mol | Exact mass | 10mM in DMSO |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
